latest news releases from the newsroom
Cycle Country Reports Superior 2nd Quarter Results:
MILFORD, Iowa, May 11, 2004 (PRIMEZONE) -- Cycle Country Accessories Corp. (AMEX:ATC), the recognized leader in developing and manufacturing a variety of products for all-terrain vehicles (ATVs), garden tractors, and golf carts, reported record results for the second quarter of fiscal 2004.
Board convenes an Extraordinary General Meeting on June 16, 2004 for implementation of the share redemption offer
STOCKHOLM, Sweden, May 11, 2004 (PRIMEZONE) -- (ELUX) The Annual General Meeting on April 21, 2004 resolved on a share redemption offer to the shareholders of Electrolux. The application period for the redemption offer runs for the period May 4 -- June 1, 2004. The Board of Directors of Electrolux has today decided to convene an Extraordinary General Meeting to be held on June 16, 2004, at which the shareholders are proposed to adopt the resolutions required for implementation of the redemption offer.
Allied Irish Banks, p.l.c.
Allied Irish Banks, p.l.c. (AIB), Statement in Relation to Foreign Exchange Charges
DUBLIN, Ireland, May 11, 2004 (PRIMEZONE) -- AIB Chairman Mr. Dermot Gleeson having consulted with Irish Financial Services Regulatory Authority (IFSRA) has today taken steps to set up an independent investigation of foreign exchange charges made by AIB. The investigation will be directed by a person of undoubted independence, who will provide assurance to the Board of AIB and to IFSRA of the completeness and independence of the investigation. This individual, who will be named within a week, will have access to external independent audit expertise in carrying out the investigation. The full investigation will be completed by mid-June.AIB estimates that its records should enable it by itself to identify, contact and reimburse at least two-thirds of the customers involved and deal with over 80 per cent of the amount to be reimbursed. We believe that with the co-operation of customers, the great majority of the remaining transactions can be identified and customers reimbursed. A simple process for dealing with these cases will be published shortly.
Electrolux will close vacuum cleaner factory in Vastervik, Sweden
STOCKHOLM, Sweden, May 11, 2004 (PRIMEZONE) -- (ELUX) Electrolux has decided to discontinue production of vacuum cleaners in Vastervik, Sweden. Production will gradually be transferred to the Electrolux vacuum cleaner factory in Hungary. Production will continue during 2004, and is expected to end in the first quarter of 2005.
Press Release from Skandia's board: Skandia's board has named Jan Erik Back and Michael Wolf as Executive Vice Presidents of Skandia
STOCKHOLM, Sweden, May 11, 2004 (PRIMEZONE) -- Skandia's Executive Management consists, in addition to President and CEO Hans-Erik Andersson, of Executive Vice President Jan Erik Back (CFO), Jan-Mikael Bexhed Executive Vice President (Corporate Law), Executive Vice President Odd Eiken (Communication & Strategy), Executive Vice President Gert Engman (Head of Sweden Division from 1 August 2004), Jennifer Rhule (Human Resources), Executive Vice President Alan Wilson (UK & Asia-Pacific), and Executive Vice President Michael Wolf (Europe and Latin America).
Xenova Group PLC
Xenova and FDA reach agreement on SPA Phase III trial programme for TransMID -- Enrollment to Begin Immediately
SLOUGH, U.K. May 11, 2004 (PRIMEZONE) -- Xenova Group plc (LSE:XEN) (Nasdaq:XNVA) announced today that it has reached agreement with the US Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) procedure for the revised Phase III clinical trial programme proposed for TransMID(TM).Prior to its acquisition by Xenova, KS Biomedix Holdings plc (KS Biomedix) had obtained FDA agreement for a single Phase III clinical trial for TransMID(TM) under the SPA process. Following the acquisition of KS Biomedix, Xenova submitted a revised programme involving two smaller sequential Phase III clinical trials rather than one larger study, which has now been agreed with the FDA. The adoption of a two study approach reduces the level of risk associated with a large single study.